Phase II and Phase III attrition rates 2011–2012
Year: 2013
Type: other
Source: Nature Reviews Drug Discovery
DOI: 10.1038/nrd4090
Authors: John Arrowsmith, Philip Miller
Institution: Thomson Reuters (United Kingdom)
Language: English
Subfield: Statistics and Probability
Field: Mathematics
Domain: Physical Sciences
Open Access status: closed
OpenAlex ID: W1968779484
